The history of Viagra presents a nuanced case for investors in the drug sector. While initially a blockbuster success, generating vast sums, the exclusivity end and the subsequent flood of off-brand versions have considerably changed revenue. This poses questions about the long-term sustainability of similar drug developments and suggests that j… Read More